Respiratory Care Devices Market Research Report ‚Äď Forecast to 2030

Respiratory Care Devices Market: Therapeutic devices (PAP Devices), Monitoring devices (Pulse Oximeters), Diagnostic devices (Spirometers), Accessories & Consumables (Disposable Masks), and Application (Asthma and Others)- Forecast till 2030

ID: MRFR/MED/5055-HCR | 85 Pages | Author: Kinjoll Dey | March 2024         

Respiratory Care Devices Market Speak to Analyst Request a Free Sample

Respiratory Care Devices Market Overview


 The Respiratory Care Devices Market is anticipated to reach USD 19.84 Billion by 2030 at 8.60% CAGR during the forecast period 2022-2030. Patients with cardiopulmonary devices are treated, assessed, diagnosed, and cared for using respiratory care equipment. There are lung disorders such as chronic bronchitis, TB, acute and chronic pulmonary diseases, asthma, and others that are treated with respiratory care devices. As people get older, the function of their lungs begins to deteriorate, causing physiological, functional, and immunological alterations in the respiratory system. Chronic pulmonary illnesses, asthma, and other respiratory ailments are on the rise, fueling market expansion. The gadgets, which have evolved from stationary to portable, can be employed in hospitals and in-home care settings.

Respiratory care devices benefit patients with chronic and acute respiratory disorders. As we age, the respiratory system goes through major anatomical, psychological, and immunological modifications. Respiratory care devices treat lung ailments such as chronic bronchitis, TB, chronic and acute lung conditions, asthma, and others. As people age, their lungs start to function worse, which leads to changes in the respiratory system's physiology, functionality, and immune system. Asthma and other respiratory conditions are becoming more prevalent, driving market growth. The thoracic spine and chest wall deformities, among other anatomical anomalies, obstruct the function of the respiratory system and lead to breathing issues. The rise in chronic obstructive pulmonary disease has substantially impacted the market for respiratory care devices.


As the world's population ages and environmental variables affect respiratory health, there is more of a demand for respiratory care equipment. The medical supplies and apparatus referred to as respiratory care equipment, assist patients in controlling respiratory conditions or providing breathing support when required. To recognize, treat, and keep track of respiratory problems, these devices are used in various healthcare settings, including clinics, hospitals, and home care settings. Some of the important variables projected to raise the demand for efficient respiratory devices for diagnosing and monitoring respiratory disorders are the rising prevalence of respiratory illnesses, evolving habits, and an increase in pollution levels.


The requirement for respiratory devices is anticipated to expand over the projected period due to rising technological breakthroughs in respiratory equipment, their convenience of use, and the increasing prevalence of different respiratory disorders worldwide. Increasing government and industry spending on R&D initiatives is also anticipated to fuel market expansion for novel respiratory devices throughout the forecast period. Devices that administer therapeutic aerosols, humidify inspired gas, provide more oxygen, and remove airway secretions are all employed in respiratory treatment. Different supplemental oxygen delivery methods have varying degrees of success in increasing the inspired oxygen concentration.


News:


A technology created by University of Canterbury researchers gives clinicians and patients easier access to respiratory data. A group of PhD students at UC Engineering created software dubbed Breath-to-Breath Observed Biometrics (BOB), which offers real-time breath-to-breath data. It can also evaluate this data and produce a report for doctors to assist in data-driven care. Researchers developed the software after observing how difficult it is for care teams and even patients to access respiratory data. Their creation makes regular condition monitoring and more automated diagnosis possible, which reduces the burden on the entire healthcare system. Physicians can use BOB to modify care if it is no longer the best option.


The most recent and serious of these disorders is COVID-19, which has resulted in a surge in demand for personal protective equipment and ventilators, among other things. The market is expected to increase due to factors such as the rising prevalence of respiratory disorders, the growing geriatric population, urbanization and its negative consequences, and changes in the environment and lifestyle. The rising need for point-of-care diagnostic devices in developing countries is expected to open up new prospects for respiratory care device manufacturers. Because of the COVID-19 outbreak, demand for ventilators has increased, leading to government and industry support to accelerate production. As a result of the increased focus on respiratory treatment in the context of an outbreak, the market is likely to develop at a strong rate.

Respiratory Care Devices Market Segmentation


The respiratory care devices market has been segmented on the basis of therapeutic devices, monitoring devices, diagnostic devices, accessories and consumables, application, and end-users.


Respiratory Care Therapeutic Devices Insights


On the basis of therapeutic devices, the market has been classified as pap devices, masks, ventilators, nebulizers, humidifiers, oxygen concentrators, inhalers, reusable resuscitators, nitric oxide delivery units, and oxygen hoods.

Respiratory Care Monitoring Devices Insights


On the basis of monitoring devices, the market has been classified as pulse oximeters, pulse oximeter sensors, pulse oximeter equipment, capnographs, and gas analyzers.


Respiratory Care Diagnostic Devices Insights


On the basis of diagnostic devices, the market has been classified as spirometers, polysomnography (PSG) devices, peak flow meters, and other diagnostic devices.

Respiratory Care Devices Accessories and Consumables Insights


On the basis of accessories and consumables, the market has been classified as disposable masks, disposable resuscitators, tracheostomy tubes, nasal cannulas, and other consumables and accessories.

Respiratory Care Devices Application Insights
On the basis of application, the market has been classified as chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases, and other diseases.

Respiratory Care Devices End-Users


On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory care, home care, and others.


Respiratory Care Devices Region Insights


On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.


The European respiratory care devices market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The respiratory care devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The respiratory care devices market in the Middle East and Africa has been segmented into the Middle East and Africa.


Respiratory Care Devices Market Regional Market Summary


In the respiratory care devices market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures. According to the Centers for Disease Control and Prevention, in 2015, the number of deaths due to chronic lower respiratory diseases (including asthma) in the US were 155,041 and the number of adults diagnosed with chronic bronchitis was 8.9 million.


The European market is expected to hold the second largest market share. The market growth in this region can be attributed to the rising frequency of diabetic patients, an increasing number of surgeries, and the increasing demand for advanced treatment procedures. According to Eurostat statistics in 2014, there were nearly 382 thousand deaths in the European Union due to respiratory diseases. According to the Global Status Report on Non-Communicable Diseases, 2010 by the World Health Organization (WHO), smoking is predicted to cause about 71% of all lung cancer deaths and 42% of chronic respiratory diseases worldwide.


The Asia-Pacific market is expected to be the fastest growing segment in the near future due to the most dominant causes of respiratory illness and mortality that include tobacco smoking, infections, and air pollution. Factors such as access to optimal treatment facilities, better adoption rate, increase in disposable income, and rising medical tourism help to boost the fastest growing region. The government and NGO's are taking numerous initiatives to spread public awareness and control of the environment regarding the prevention and treatment of respiratory diseases.


The market in the Middle East and Africa is expected to account for the smallest share of the global respiratory care devices market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the global respiratory care devices market are Philips Healthcare (Netherlands), ResMed, Inc. (US), Medtronic plc (Ireland), Masimo Corporation (US), and Fisher & Paykel Healthcare Corporation Limited (New Zealand), Becton, Dickinson and Company (US), Chart Industries, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), and Hamilton Medical AG (Switzerland).


Respiratory Care Devices Market Segmentation


Respiratory Care Devices Therapeutic Devices Outlook



  • Pap devices

  • Masks

  • Ventilators

  • Nebulizers

  • Humidifiers

  • Oxygen concentrators

  • Inhalers

  • Reusable resuscitators

  • Nitric oxide delivery units

  • Oxygen hoods


Respiratory Care Devices Monitoring Devices Outlook



  • Pulse oximeters

  • Pulse oximeter sensors

  • Pulse oximeter equipment

  • Capnographs

  • Gas analyzers


Respiratory Care Devices Diagnostic Devices Outlook



  • Spirometers

  • Polysomnography (PSG) Devices

  • Peak Flow Meters

  • Other Diagnostic Devices


Respiratory Care Devices Accessories and Consumables Outlook



  • Disposable masks

  • Disposable resuscitators

  • Tracheostomy tubes

  • Nasal cannulas

  • Other consumables and accessories


Respiratory Care Devices Application Outlook



  • Chronic obstructive pulmonary disease (COPD)

  • Sleep apnea

  • Asthma

  • Infectious diseases

  • Other diseases


Respiratory Care Devices End-Users Outlook



  • Hospitals

  • Clinics

  • Ambulatory care

  • Home care 

  • Others


Respiratory Care Devices Region Outlook


Americas

  • North America

  • US

  • Canada

  • South America


Europe

  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe


Asia-Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific


Middle East & Africa

  • Middle East

  • Africa


Recent Development


Dragerwerk AG & CO. KGAA unveiled the Oxylog VE300, a newly developed emergency and transport ventilator that is especially well suited for use outside of the hospital environment, in May 2017. Philips will release the PHILIPS RESPIRONICS E30 VENTILATOR in April 2020. As a result, the company will be able to assist healthcare professionals by offering high-quality ventilators. Masimo Corporation purchased NantHealth's Connected Care Business in January 2020. Through connectivity, automation, and breakthrough noninvasive monitoring technologies, Masimo will be able to aid hospitals in providing constant care.

Intended Audience



  • Respiratory care device manufacturers and distributors

  • Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)

  • Research institutes

  • Contract manufacturing organizations (CMOs)

  • Government associations

  • Market research and consulting firms

  • Venture capitalists and investors


Report Scope:

Report Attribute/Metric Details
  Market Size   USD 19.84 Billion
  CAGR   8.60%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Therapeutic Devices, Monitoring Devices, Diagnostic Devices, Accessories and Consumables, Application and End-users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Philips Healthcare (Netherlands), ResMed, Inc. (US), Medtronic plc (Ireland), Masimo Corporation (US), and Fisher & Paykel Healthcare Corporation Limited (New Zealand), Becton, Dickinson and Company (US), Chart Industries, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), and Hamilton Medical AG (Switzerland)
  Key Market Opportunities   Growing demand for point-of-care diagnostic devices in developing regions
  Key Market Drivers ·  Increasing frequency of respiratory diseases ·  Increasing geriatric population, urbanization, and its adverse effects ·  Changes in the environment and lifestyle




Frequently Asked Questions (FAQ) :

The Respiratory care devices market is expected to growth at 8.60% CAGR during the forecast period (2022–2030).

The major key players of global respiratory care devices market are Philips Healthcare (Netherlands), ResMed, Inc. (US), Medtronic plc (Ireland), Masimo Corporation (US), and Fisher & Paykel Healthcare Corporation Limited (New Zealand), Becton, Dickinson and Company (US), Chart Industries, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), and Hamilton Medical AG (Switzerland).

The lack of awareness about respiratory problems, intense competition, and the cost associated with the device and the respiratory surgery restraints of Respiratory Care Devices Market.

Increasing frequency of respiratory diseases, increasing geriatric population, urbanization, and its adverse effects, and changes in the environment and lifestyle boosts the growth of the Respiratory Care Devices Market.

By 2030, the Medical Device Cleaning Market value can exceed USD 19.84 Billion .

Key Questions Answered

  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players‚Äô financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample

Why Choose Market Research Future?

  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst
Leading companies partner with us for data-driven Insights.
Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid